Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
paola.infante@uniroma1.it
Paola Infante
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA MOLECOLARE
E-mail:
paola.infante@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Potential of a natural compound as Hedgehog pathway inhibitor for the treatment of Intrahepatic Cholangiocarcinoma
30° CONGRESSO NAZIONALE DELLE MALATTIE DIGESTIVE
2024
Dissecting the hindrance of Hedgehog pathway in Intrahepatic Cholangiocarcinoma: a step towards targeted therapy
UNITED EUROPEAN GASTROENTEROLOGY JOURNALUNITED EUROPEAN GASTROENTEROLOGY JOURNAL
2024
Exploring the potential of anthraquinone-based hybrids for identifying a novel generation of antagonists for the Smoothened receptor in HH-dependent tumour
CHEMISTRY
2023
SALL4 is a CRL3^REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma
CELL DEATH AND DIFFERENTIATION
2023
Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors?
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
2022
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2022
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma
CANCER LETTERS
2021
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors
ONCOGENE
2021
Design and synthesis of new withaferin A inspired hedgehog pathway inhibitors
CHEMISTRY-A EUROPEAN JOURNAL
2021
Harnessing the activation of RIG-I like receptors to inhibit glioblastoma tumorigenesis
FRONTIERS IN MOLECULAR NEUROSCIENCE
2021
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples
ELIFE
2021
Drug delivery systems for hedgehog inhibitors in the treatment of SHH-medulloblastoma
FRONTIERS IN CHEMISTRY
2021
Phenformin inhibits hedgehog-dependent tumor growth through a complex i-independent redox/corepressor module
CELL REPORTS
2020
The rna-binding ubiquitin ligase mex3a affects glioblastoma tumorigenesis by inducing ubiquitylation and degradation of rig-i
CANCERS
2020
Hedgehog signaling pathway inhibitors: an updated patent review (2015–present)
EXPERT OPINION ON THERAPEUTIC PATENTS
2020
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer
FRONTIERS IN ONCOLOGY
2020
Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation
CELL DEATH & DISEASE
2020
Nutlin-3a enhances natural killer cell-mediated killing of neuroblastoma by restoring p53-dependent expression of ligands for NKG2D and DNAM-1 receptors
CANCER IMMUNOLOGY RESEARCH
2020
The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma
EXPERT OPINION ON THERAPEUTIC TARGETS
2020
Dubs activating the hedgehog signaling pathway: a promising therapeutic target in cancer
CANCERS
2020
1
2
3
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma